Literature DB >> 7432725

Rapid gentamicin elimination in obstetric patients.

D E Zaske, R J Cipolle, R G Strate, J W Malo, M F Koszalka.   

Abstract

Wide interpatient variation in gentamicin elimination rates and dosage requirements was demonstrated in 67 obstetric patients with normal serum creatinine levels. A poor correlation occurred between the elimination rate of gentamicin and creatinine clearance (r = .23). A higher correlation was found between the drug's elimination rate and distribution volume (r = -.62), which suggests that the changing fluid status associated with pregnancy affects the kinetic parameters of gentamicin. Gentamicin dosage regimens were systematically calculated for each patient from serum concentration-time data to obtain desired serum levels. These individualized regimens demonstrated considerable variability, ranging from 3.0 to 11.6 mg/kg/day. Clinical ototoxicity and nephrotoxicity were not observed. Because of the wide interpatient variation, these increased dosages are not routinely suggested unless serum concentrations are previously measured and each patient's regimen is calculated. These results emphasize the need to measure serum concentrations and make necessary dosage adjustments to ensure therapeutic levels in obstetric patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7432725

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients.

Authors:  E Hassan; J D Ober
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

2.  Easier monitoring of aminoglycoside therapy with once-daily dosing schedules.

Authors:  J M Prins; R P Koopmans; H R Büller; E J Kuijper; P Speelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

3.  Influence of age on tobramycin pharmacokinetics in patients with normal renal function.

Authors:  L A Bauer; R A Blouin
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

4.  Gentamicin volume of distribution in critically ill septic patients.

Authors:  C Triginer; I Izquierdo; R Fernández; J Rello; J Torrent; S Benito; A Net
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 5.  Pharmacokinetics of antiretrovirals in pregnant women.

Authors:  Mark Mirochnick; Edmund Capparelli
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 6.  Pharmacotherapy of pediatric HIV infection.

Authors:  Natella Rakhmanina; B Ryan Phelps
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

Review 7.  Once-daily dosing of gentamicin in obstetrics and gynecology.

Authors:  Kristy Ward; Regan N Theiler
Journal:  Clin Obstet Gynecol       Date:  2008-09       Impact factor: 2.190

8.  Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.

Authors:  J D Blanco; R S Gibbs; P Duff; Y S Castaneda; P J St Clair
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.

Authors:  C H King; R J Creger; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

Review 10.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.